144 related articles for article (PubMed ID: 2567155)
1. Synthesis of 3-[2-(2,3-dihydro-5-phenyl-4-substituted-3H-1,2,4- triazole-3-thione-2-yl)-acetylamino]-2-methyl-4(3H)-quinazolinones and their pharmacological activities.
Büyüktimkin S; Büyüktimkin N; Ozdemir O; Rollas S
Arch Pharm (Weinheim); 1989 Jan; 322(1):49-51. PubMed ID: 2567155
[TBL] [Abstract][Full Text] [Related]
2. [Quinazolinones. 16. Synthesis and in vitro pharmacology of 2-aryl-1- ([3-(imidazol-4-yl)propyl]-guanidinylalkyl)-2,3-dihydro-4(1H)- quinazolinones].
Büyüktimkin S; Buschauer A; Schunack W
Arch Pharm (Weinheim); 1989 Feb; 322(2):115-8. PubMed ID: 2567156
[TBL] [Abstract][Full Text] [Related]
3. [Quinazolinones. 18. Synthesis and H1/H2-antihistaminic action of omega-[2-aryl-2,3-dihydro-4(1H)-quinazolinone-1-yl]alkyl substituted ureas and cyanoguanidines].
Büyüktimkin S; Buschauer A; Schunack W
Arch Pharm (Weinheim); 1991 May; 324(5):291-5. PubMed ID: 1679625
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and pharmacological investigation of some novel 2-phenyl-3-(substituted methyl amino) quinazolin-4(3H)-ones as H1-receptor blockers.
Alagarsamy V; Venkatesaperumal R; Vijayakumar S; Angayarkanni T; Pounammal P; Senthilganesh S; Kandeeban S
Pharmazie; 2002 May; 57(5):306-7. PubMed ID: 12061252
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of novel 2-(3-substituted propyl)-3-(2-methyl phenyl) quinazolin-4-(3H)-ones as a new class of H1-antihistaminic agents.
Alagarsamy V; Parthiban P
J Enzyme Inhib Med Chem; 2013 Feb; 28(1):65-71. PubMed ID: 22074561
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and pharmacological investigation of some novel 2-methyl-3-(substituted methylamino)-(3H)-quinazolin-4-ones as histamine H1-receptor blockers.
Alagarsamy V
Pharmazie; 2004 Oct; 59(10):753-5. PubMed ID: 15544052
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and H1-antihistaminic activity of beta-alkoxyethyl and beta-(N,N-dialkylamino)ethyl-(3-aryl-3,4-dihydro-4-oxoquinazolin- 2-yl)m ethyl ethers.
Rao AR; Reddy VM
Pharmazie; 1992 Oct; 47(10):794-6. PubMed ID: 1362273
[No Abstract] [Full Text] [Related]
8. Bioisosteric transformation of H1-antihistaminic benzimidazole derivatives.
Iemura R; Hori M; Saito T; Ohtaka H
Chem Pharm Bull (Tokyo); 1989 Oct; 37(10):2723-6. PubMed ID: 2575462
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacological investigation of novel 4-(3-ethylphenyl)-1-substituted-4H-[1,2,4]triazolo[4,3-a] quinazolin-5-ones as a new class of H1-antihistaminic agents.
Alagarsamy V; Kavitha K; Rupeshkumar M; Solomon VR; Kumar J; Kumar DS; Sharma HK
Acta Pharm; 2009 Mar; 59(1):97-106. PubMed ID: 19304562
[TBL] [Abstract][Full Text] [Related]
10. [Synthesis and pharmacologic action of substituted imidazolyl- and thiazolylmethylthioethylguanidine].
Buschauer A
Arzneimittelforschung; 1987 Sep; 37(9):1003-7. PubMed ID: 2893625
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and histamine H2-antagonist activity of 4-quinazolinone derivatives.
Ogawa N; Yoshida T; Aratani T; Koshinaka E; Kato H; Ito Y
Chem Pharm Bull (Tokyo); 1988 Aug; 36(8):2955-67. PubMed ID: 2907306
[No Abstract] [Full Text] [Related]
12. [H2-antihistaminics. 31. 1,2,5-Triazine-2,4-diamines and -2,4,6-triamines with H2-antagonistic activity].
Mohr R; Buschauer A; Schunack W
Arch Pharm (Weinheim); 1986 Oct; 319(10):878-85. PubMed ID: 2878652
[No Abstract] [Full Text] [Related]
13. Synthesis and antiproliferative activity of novel 3-(indazol-3-yl)-quinazolin-4(3H)-one and 3-(indazol-3-yl)-benzotriazin-4(3H)-one derivatives.
Raffa D; Daidone G; Maggio B; Schillaci D; Plescia F
Arch Pharm (Weinheim); 1999 Sep; 332(9):317-20. PubMed ID: 10520301
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological investigation of novel 1-substituted-4-phenyl-1,2,4-triazolo[4,3-a]quinazolin-5(4H)-ones as a new class of H1-antihistaminic agents.
Alagarsamy V; Giridhar R; Yadav MR
Bioorg Med Chem Lett; 2005 Apr; 15(7):1877-80. PubMed ID: 15780625
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 4-butyl-1-substituted-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones as new class of H(1)-antihistaminic agents.
Alagarsamy V; Shankar D; Murugesan S
Biomed Pharmacother; 2008 Mar; 62(3):173-8. PubMed ID: 17936567
[TBL] [Abstract][Full Text] [Related]
16. Quinazolinones. 19. Communication [1]: synthesis and evaluation of some CNS depressant properties of 3-(2-[(5-aryl-1,3,4-oxadiazole-2-yl)amino]acetamido)-2-methyl-4 (3H)-quinazolinones.
Ergenç N; Büyüktimkin S; Capan G; Baktir G; Rollas S
Pharmazie; 1991 Apr; 46(4):290-1. PubMed ID: 1886919
[No Abstract] [Full Text] [Related]
17. Synthesis and pharmacological investigation of novel 4-benzyl-1-substituted-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones as new class of H1-antihistaminic agents.
Alagarsamy V; Solomon VR; Murugan M
Bioorg Med Chem; 2007 Jun; 15(12):4009-15. PubMed ID: 17452107
[TBL] [Abstract][Full Text] [Related]
18. Syntheses of the metabolites of 1-(2-ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-1H benzimidazole difumarate (KG-2413) and related compounds.
Iemura R; Hori M; Ohtaka H
Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):962-6. PubMed ID: 2569942
[TBL] [Abstract][Full Text] [Related]
19. [Synthesis and H2-antihistaminic activity of 2-amidino-1,2-dihydro-3h-pyrazol-3-ones].
Wegner K
Arch Pharm (Weinheim); 1983 Jan; 316(1):2-6. PubMed ID: 6131659
[No Abstract] [Full Text] [Related]
20. 4-(3-Methoxyphenyl)-1-substituted-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones: new class of H1-antihistaminic agents.
Alagarsamy V; Sharma HK; Parthiban P; Singh JC; Murugan ST; Solomon VR
Pharmazie; 2009 Jan; 64(1):5-9. PubMed ID: 19216223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
